Toxicity Evaluations And Risk Assessment

EVALUTATING EFFECTS FROM EMERGING CONTAMINANTS

GSI helps our clients navigate the challenges of unregulated chemicals or chemicals with evolving requirements by bringing our multi-disciplinary team with in-depth technical, litigation, and regulatory expertise.

Our Diplomates of the American Board of Toxicology and team of toxicologists and risk assessors have conducted baseline risk assessments, product risk assessments, critical evaluations of agency reviews and decisions, written peer reviewed publications, book chapters, and novel toxicity assessments and frameworks, and continue to work with our clients to ensure that the most scientifically justified information is used to make risk management decisions for emerging contaminants. Our toxicologists are internationally known experts in PFAS, 1,4-dioxane, 1,2,3-TCP, microplastics, and other emerging contaminants.

FEATURED PROJECTS

Baseline Human Health Risk Assessment for PFAS, Confidential Location,

GSI leads several CERCLA PFAS baseline human health and ecological risk assessments. Our staff develop the conceptual site models for assessing human and ecological receptor exposures, negotiate the selection of toxicity values, manage the field biota sampling and analysis to develop site-specific exposure information, and successfully conduct the baseline risk assessment in accordance with federal and state statutes and guidance.

Baseline Human Health Risk Assessment for PFAS

Confidential Location,

GSI leads several CERCLA PFAS baseline human health and ecological risk assessments. Our staff develop the conceptual site models for assessing human and ecological receptor exposures, negotiate the selection of toxicity values, manage the field biota sampling and analysis to develop site-specific exposure information, and successfully conduct the baseline risk assessment in accordance with federal and state statutes and guidance.

Contact Us

Janet Anderson, PhD, DABT

Principal Toxicologist